Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

65.62 -1.04 (-1.56%)
Official Closing Price Updated: 7:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CVS Health Corp

< Previous 1 2 3 4 5 6 Next >
CVS INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS
WHY: NEW YORK, NY - (NewMediaWire) - May 12, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CVS Health... 
Via TheNewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
The sudden divergence has made clear some laggards who have ultra-low RSI readings that might just be too good to ignore. Here are 3 worth watching closely. 
Via MarketBeat
Topics Economy
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS
From The Rosen Law Firm, P.A.
Via Business Wire
CVS Corp. (NYSE: CVS) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Health insurer Humana reported Q1 2024 earnings, getting a less dramatic reaction than its Q4 2023 report, causing shares to tumble more than 13%. 
Via MarketBeat
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year. 
Via MarketBeat
DoorDash: 5 Compelling Reasons to Buy the Dip
DoorDash Inc. (NASDAQ: DASH) is the leading restaurant and food delivery service in the United States - should you buy the dip? 
Via MarketBeat
Topics Death
5 High-Yielding Oversold Stocks with Bullish Ratings
Investors have favored defensive sectors in the short term, and oversold high-yielding names might become more in play as tensions rise and the market pulls in. 
Via MarketBeat
Topics Economy
The Honest Company is Undergoing an Honestly Solid Turnaround
The Honest Company stock is up 30% after the company issued a bullish outlook for 2024 revenue and earnings, particularly in the second half of the year 
Via MarketBeat
Topics Initial Public Offering
AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna
From AM Best
Via Business Wire
Can UnitedHealth Group afford to keep Medicare Advantage plans?
UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop 
Via MarketBeat
S&P 500 rockets to new highs as earnings beat estimates
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. 
Via MarketBeat
Topics ETFs Earnings Stocks
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance 
Via MarketBeat
MarketBeat Week in Review – 1/15 - 1/19
The market continues to bounce back and forth as investors wait on news from the Federal Reserve later this month, but inflation may still be the bigger story 
Via MarketBeat
Topics Economy
Are CVS store closures prescription for better financial health?
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry. 
Via MarketBeat
Topics Economy
Walgreens Boots Alliance: Is it time to take this Dog for a walk?
Walgreens cut its dividend in half to right-size the payment and preserve cash flow; the stock still yields about 4% and trades at a deep value. 
Via MarketBeat
Topics Stocks
Quick list of bargain stocks to end the year
Stocks are soaring after a FED dovish pivot, making these value stocks all the more attractive today. Analysts have built up cases as to why they will rally 
Via MarketBeat
MarketBeat Week in Review – 12/4 - 12/8
Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week 
Via MarketBeat
Topics Economy
Is CVS stock ready for a rebound?
After consolidating from this year's selloff, for those of us on the sidelines, this is about as clear a low as you can expect to see. 
Via MarketBeat
Mega merger in the works? Humana, Cigna explore big deal
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion. 
Via MarketBeat
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
3 value stocks you shouldn't let go of this quarter
The market has created the perfect opportunity for you to have your cake and eat it too. These three value stocks will likely be portfolio residents soon 
Via MarketBeat
Topics Bankruptcy
High-yield, low-beta value plays for buy-and-hold investors
High-yield stocks that trade at a value and come with a lower-than-average beta can help mitigate portfolio volatility and boost returns over time. 
Via MarketBeat
Topics Economy
3 healthy dividend stocks for buy and hold investors
Blue chip healthcare stocks like health insurers are supported by secular tailwinds and pay reliable dividends with an outlook for health growth 
Via MarketBeat
Topics Artificial Intelligence
Walgreen's Fresh New Lows, Is The Dividend Worth The Ride?
Walgreens stock became a clear value play, offering an attractive dividend yield and tailwinds to position it as an industry leaders are two reasons to watch 
Via MarketBeat
Topics Bonds Economy
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.